TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $19,240,000 | +58.0% | 698,620 | -5.4% | 0.00% | +50.0% |
| Q1 2021 | $12,174,000 | -14.2% | 738,192 | -4.1% | 0.00% | -33.3% |
| Q4 2020 | $14,190,000 | +33.5% | 769,987 | -1.4% | 0.00% | +50.0% |
| Q3 2020 | $10,632,000 | +30.2% | 781,235 | +71.5% | 0.00% | 0.0% |
| Q2 2020 | $8,164,000 | +84.7% | 455,624 | +2.8% | 0.00% | +100.0% |
| Q1 2020 | $4,419,000 | +32.4% | 443,207 | +8.1% | 0.00% | 0.0% |
| Q4 2019 | $3,338,000 | -0.1% | 410,092 | +21.6% | 0.00% | 0.0% |
| Q3 2019 | $3,341,000 | -14.7% | 337,186 | +8.7% | 0.00% | 0.0% |
| Q2 2019 | $3,919,000 | +33.2% | 310,246 | +7.5% | 0.00% | 0.0% |
| Q1 2019 | $2,942,000 | +252.3% | 288,653 | +159.3% | 0.00% | – |
| Q4 2018 | $835,000 | -15.7% | 111,339 | +12.4% | 0.00% | – |
| Q3 2018 | $991,000 | – | 99,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,437,601 | $24,376,000 | 11.53% |
| DAFNA Capital Management LLC | 151,739 | $1,517,000 | 0.62% |
| Bain Capital Public Equity Management, LLC | 738,543 | $7,385,000 | 0.52% |
| Baupost Group | 6,491,287 | $62,393,000 | 0.48% |
| Rock Springs Capital Management LP | 1,009,179 | $10,092,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 276,639 | $2,766,000 | 0.32% |
| Cormorant Asset Management, LP | 454,550 | $4,546,000 | 0.30% |
| Artal Group S.A. | 600,000 | $6,000,000 | 0.16% |
| Perceptive Advisors | 500,000 | $5,000,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 367,744 | $3,677,000 | 0.03% |